Growth hormone (GH) secretion is vividly pulsatile in all mammalian species studied. In a simplified model, self-renewable GH pulsatility can be reproduced by assuming individual, reversible, time-delayed and threshold-sensitive hypothalamic outflow of GH-releasing hormone (GHRH) and GH release-inhibiting hormone (somatostatin, SRIF). However, this basic concept fails to explicate an array of new experimental observations. Accordingly, here we formulate and implement a novel fourfold ensemble construct, wherein: (i) systemic GH pulses stimulate long-latency, concentration-dependent secretion of periventricular-nuclear SRIF, thereby initially quenching and then releasing multiphasic GH volleys (recurrent every 3 to 3.5 h); (ii) SRIF delivered to the anterior pituitary gland competitively antagonizes exocytotic release, but not synthesis, of GH during intervolley intervals; (iii) arcuate-nucleus GHRH pulses drive the synthesis and accumulation of GH in saturable somatotrope stores; and (iv) a purely intrahypothalamic mechanism sustains high-frequency GH pulses (intervals of 30 to 60 min) within a volley, assuming short-latency reciprocal coupling between (a) GHRH and SRIF neurons (stimulatory direction) and (b) SRIF and GHRH neurons (inhibitory direction). This two-oscillator formulation explicates (but does not prove): (1) the GHRH-sensitizing action of prior somatostatin exposure; (2) a three-site (intrahypothalamic, hypothalamo-pituitary and somatotrope GH store-dependent) mechanism driving rebound-like GH secretion after somatostatin withdrawal in the male; (3) an obligatory role for pituitary GH stores in representing rebound GH release in the female; (4) greater irregularity of SRIF than GH release profiles; and (5) a basis for the paradoxical GH-inhibiting action of centrally delivered GHRH.
INTRODUCTION
The secretion of GH is pulsatile in the human, monkey, sheep, swine, guinea pig, rat and mouse (10, 20, 21, 30, 34, 37, 40, 48, 49) . In the rodent, episodic GH release direct somatic growth, cellular gene expression and autonegative feedback (3, 20, 31, 34, 37, 42) . A distinctive feature of pulsatile GH secretion is the dual representation of (i) multiburst volleys, which recur every 3 to 3.5 h in the adult male rat and every 1.5 to 2.5 h in men and women; and (ii) rapid discrete GH pulses, which arise every 30-60 min within an individual volley (19, 20, 21, 22, 30, 37, 38, 42, 48, 49) . Such complex patterns of GH release are evident by high-frequency (0.5 and 5-min) sampling paradigms in the unanesthetized rat, sheep and healthy human (19, 22, 23, 37, 38, 42, 49) . The mechanisms that generate composite low-frequency volleys and highfrequency GH bursts are not established.
Our earlier construction of a regulatory basis for combined GH volleys and discrete GH pulses incorporated prompt autofeedback by secreted GH on GHRH outflow (thereby eliciting rapidly recurrent events) and delayed feedforward by GH on SRIF release (thus terminating a volley). In essence, this notion defines two systemichypothalamic oscillators with distinguishable sensitivities and periodicities (14) . The resultant GH secretory pattern is self-renewing, emulates that of the adult male rat, and is adaptable to female dynamics by gender-specific relaxation of GH-induced SRIF release (15) . However, the purely systemic-CNS feedback structure fails to account for other fundamental experimental observations. The latter include: (i) continued GH pulsatility under constant systemic GHRH stimulation; (ii) a paradoxical suppressive R-00086-2003 R1 effect of central GHRH action; and (iii) peripheral somatostatin withdrawal-induced rebound-like secretion of GH in the adult female rat (13, 20, 27, 30, 34, 42) .
The present work formulates and implements an alternative model of GH autoregulation, which combines four distinct mechanisms: (i) long-loop, time-delayed stimulation of SRIF release by blood-borne GH (systemic-CNS control); (ii) periventricular SRIF-dependent inhibition of pituitary GH release but not synthesis (CNS-pituitary regulation); (iii) arcuate-nucleus GHRH-stimulated somatotrope GH synthesis and storage in a releasable pool (hypothalamo-pituitary pathway); and (iv) short-loop, rapid, reciprocal signaling within the hypothalamus between GHRH and SRIF, which sustains GHRH/GH pulse renewal. This construct forecasts selfregenerating GH oscillations within a volley; illustrates a mechanism for GH pulsatility in the face of continuous GHRH drive; and, explicates post-somatostatin rebound GH secretion in the female.
METHODS

Core GH network
The core ensemble comprises seven principal feedforward and feedback linkages among GH, GHRH and SRIF: Figure 1 . At any given moment, GH output reflects these primary physiological interactions, which are transduced by implicit effector dose-response interface functions. Individual peptide elimination rates are assumed to be distinct and stable. The primary network-like connections (and their experimental derivation) are: [1] GHRH's acute stimulation of GH release from somatotrope cells (8, 18, 26, 30, 37, 42, 43, 45, 46) ; [2] SRIF's antagonism of GHRH-
induced GH secretion (18, 20, 34, 42) ; [3] GH's delayed feedforward on SRIF release (6, 9, 29, 31, 34, 35, 37) ; [4] SRIF's inhibition of GHRH secretion (8, 12, 16, 24, 30) ; [5] GH's repression of GHRH outflow (7, 9, 16, 31, 32) ; [6] GHRH's time-lagged induction of pituitary SRIF secretion (1, 2, 11, 24, 27, 29, 32, 33, 34, 37, 46) ; and [7] GHRH's induction of the de novo synthesis and accumulation of (releasable) GH in the pituitary gland (20, 34, 42, 45, 46) . This ensemble formulation extends an earlier basic construct by including: (a) intrahypothalamic GHRH-evoked SRIF outflow; and (b) GHRHstimulated synthesis and accumulation of GH stores (Discussion). The interconnections defined by the above [1] - [7] interfaces yield two coupled oscillators:
(i) an intrahypothalamic GHRH-SRIF oscillator (connections [4] and [6] , above);
and (ii) a pituitary-hypothalamic GH-SRIF oscillator (driven via linkage [3] ).
The foregoing bipartite model provides a platform to examine the present new postulates that: (a) a putative CNS GHRH-SRIF oscillator will yield a high frequency of self-sustaining GH pulses within a volley; and (b) the systemic-hypothalamic GH-SRIF oscillator will confer infrequent multiphasic volleys. Concomitantly, we test GH pulse automaticity under (simulated) continuous GHRH infusion and the contribution of GHRH-enhanced (releasable) pituitary GH stores to post-somatostatin rebound-like GH secretion.
Connectivity is encapsulated in the following core equations. The prime notation denotes the time derivative (or rate of change of concentration) under feedback and feedforward inputs: [4] Italicized GH, SRIF and GHRH signify the concentration of each peptide; pool defines the GH concentration in releasable pituitary stores; M is the maximal attainable GH concentration in the pool; S min designates minimal baseline "tonic" SRIF release; is a scaling constant to relate the distribution volumes of the pituitary and systemic circulation; k 1 , k 2 and k 3 are rate constants of peptide elimination; and k r,1 , k r,2,gh , k r,2,ghrh , k r,3 and k r,4 are rate constants of release; n 0 , n 1 , n 2 , n 4 , n 5 , n 6 , n 7 and t 0 , t 1 , t 2 , t 4 , t 5 , t 6 , t 7 are Hill coefficients and thresholds, respectively, for the dose-response interfaces numbered in Figure 1 . D is the time-delay for GH's feedback on SRIF; T is the timedelay for GHRH's feedforward on SRIF; and, t 3 is the Michaelis-Menten constant defining sensitivity of SRIF feedback on GHRH.
In this formulation, the dynamics of the GH pool depend simultaneously on timevarying synthesis and release of GH. Algebraically, synthesis is represented by the first term in the right-hand side of Equation [4] . Synthesis (but not release) of GH is stimulated by GHRH (through the corresponding Hill function) even in the presence of R-00086-2003 R1 SRIF competition, and depressed as the pool approaches saturation (the term "[MPool]" in Equation [4] ). Pool saturation denotes that the maximal GH concentration attainable remains below certain asymptotic limit (the constant, "M"). Actual GH release is described by the second term in the right-hand side of equation [4] . Release is antagonized by SRIF and stimulated by GHRH, depending upon GH-pool size.
Deterministic features
The following assumptions are implicit in the interactive network represented algebraically by Equations [1] to [4] :
(a) a pulse of GH requires all three of: 
Parameter definition
A detailed justification of the choice of interface parameters is given in (14, 15 
Justification of accumulation of pituitary GH stores
In vitro and in vivo SRIF blocks the release, but not GHRH-stimulated synthesis and accumulation, of GH in somatotrope cells (18, 20, 35, 45, 46) . Equations [1] and [4] incorporate this precept by allowing GHRH to promote the (saturable) accumulation of releasable GH stores when SRIF is present. Secondarily, we test the implications of an allowance that systemic SRIF suppresses GHRH release in the arcuate nucleus
[Discussion].
R-00086-2003 R1
Rebound GH release
The network connectivity of Figure 1 permits an evaluation of the impact of feedback-dependent unleashing of acute GH secretion by sequential exposure to and withdrawal of systemic SRIF. We assess the consequences of SRIF to block GH release but not inhibit GHRH-dependent synthesis and accumulation of GH stores (20) .
The primary postulate is that post-somatostatin rebound secretion of GH arises by way of increased GH stores (due to somatostatinergic inhibition of GH release despite ongoing GH synthesis) and elevated GHRH release (due to decreased hypothalamic SRIF outflow associated with reduced GH availability for feedback) (6, 7, 16, 20, 28, 32, 37) . A complementary prediction is that hypothalamic GHRH secretion during peripheral SRIF infusion would remain pulsatile, unless circulating SRIF can enter the CNS and fully suppress GHRH release (12).
Continuous infusion of GHRH
The macromolecules injected intravenously accumulate promptly in the median eminence and arcuate nucleus, but not in the periventricular nucleus (20, 34 Simulations further illustrate that high-frequency GHRH-SRIF oscillations expressly require GHRH stimulation of SRIF. Depletion of this pathway leaves lowfrequency (approximately 3-h) pulses driven by the long-latency GH-SRIF oscillator.
RESULTS
Basic model output
High-frequency GH oscillations also disappear if T=0 (time delay for GHRH to stimulate SRIF outflow), since instantaneous SRIF release damps the intrahypothalamic GHRH-SRIF oscillator. Thus, feedback delay in this model is obligatory to sustain rapid GHRH/GH pulsatility within a volley.
Theoretical considerations and empirical observations indicate that feedback connections within an interlinked network control the serial orderliness (or sequential regularity) of output patterns (39, 41) . One objective ensemble regularity measure is the approximate entropy (ApEn) statistic, as justified earlier to compare the relative orderliness of limited time series and thereby quantitate the relative admixture of deterministic and stochastic processes (19, 38) . 
SRIF-induced rebound GH release
Systemic SRIF delivery and withdrawal was simulated as described in Methods (Paragraph 2.7) by adding a new equation [5] to the core system. The infusion term differs from zero only during the anticipated infusion period, when it equals 5000 pg.ml -1 .h -1 . The same elimination rate constants are assumed for endogenous and exogenous SRIF. Under a simplifying model assumption that exogenous SRIF does not inhibit GHRH neurons (the "infusion" C (Equation [5] ) is added to SRIF(t) in
Equations [1] and [4] , but not in Equation [3] ), pulsatile GHRH release continues despite Additional simulations show that in this model system, SRIF infusion does not disrupt GHRH pulse timing. Therefore, the magnitude of rebound GH release post-SRIF depends on the quantity of releasable GH stores, concomitant GHRH concentration and the rates of infusion and elimination of SRIF. Incomplete withdrawal of exogenous SRIF during the first post-infusion GHRH spike would limit maximal GH release. Thus, for uniformity, simulations depicted in Figure 3 illustrate termination of SRIF infusion during a GHRH zenith. but not in Equation [2] ). The latter proviso does not exclude delayed GH drive of SRIF induced by the first peak and expected hypothalamic GHRH stimulation of SRIF.
) (t
SRIF withdrawal-induced rebound secretion of GH in the female-like model
To examine postSRIF-induced rebound release of GH in a female-like construct, we attenuated GH-dependent stimulation of SRIF secretion in the male model. This adaptation is described algebraically in (15) . We then compare the magnitude of . Figure 5 illustrates that inclusion of a releasable GH pool allows rebound-like GH secretion in the female-like formulation.
R-00086-2003 R1
Continuous GHRH infusion
Continuous systemic GHRH delivery was simulated at a rate of 1,600 pg.ml -1 .h -1 with allowance for variable access of exogenous GHRH to SRIF neurons after a finite time delay. For graphical purposes, the 20-hr infusion started at 1000 and ended at 3000 h. Since CNS access of exogenous GHRH is an unknown property that could influence hypothalamo-pituitary responsiveness, we explored the impact on GH output of variable uptake of GHRH into the hypothalamus: Figure 6 . The four panels illustrate outcomes of an assumed relative availability of GHRH to the hypothalamus vis-à-vis anterior pituitary gland of 100% (1:1), 75%, 50% and 25%. Unrestricted access of GHRH to SRIF-releasing neurons in this construct represses GH pulse amplitude by delayed feedforward on SRIF. The latter phenomenon is observed following in vivo intracerebroventricular infusion of biosynthetic GHRH in the mature male rat and after in vitro incubation of GHRH with fetal hypothalamic neurons or adult median-eminence neural tissue (1, 2, 11, 27, 29, 32, 33) . In further simulations, we observed that the onset of continuous GHRH infusion initially induces high-amplitude GH pulses. Damping of GH pulse size thereafter reflects the assumed delay in cyclical GHRH-stimulated and systemic GH-induced SRIF release. The sensitivity of suppression of GH secretion to the amount of infused peripheral GHRH was explored by elevating the infusion rate by 2-fold and 8-fold: Figure 7 . In this experiment, the hypothalamic uptake of the circulating peptide was assumed to be 100%, and the feedforward latency was The current computer-assisted simulations show that intrahypothalamic oscillations between SRIF and GHRH afford a plausible mechanistic basis for the paradox of unchanged GH pulse frequency during constant GHRH infusion. For example, GH pulsatility clearly persists, but remains unexplained to date, in rare patients with ectopic (tumoral) GHRH production and in healthy individuals given constant i.v. infusion of biosynthetic GHRH (13, 20) . Patients harboring a complete inactivating (truncational) mutation of the GHRH-receptor gene also retain a normal daily frequency of GH pulses, albeit of 30-fold reduced amplitude (44) . The present analyses forecast a stable GH pulse frequency in the first two contexts, so long as systemic GHRH and GH do not directly restrain the putative hypothalamic SRIF/GHRH oscillator mechanism purported to set pulse timing. The hypothesis that the central GHRH-SRIF oscillator is isolated from systemic GHRH and GH autonegative feedback The current mechanistic formulation of high-frequency GH pulses within multiphasic volleys differs from an earlier notion (14, 15) . Specifically, the initial model does not include intrahypothalamic bidirectional coupling between GHRH and SRIF to drive high-frequency pulse renewal. Rather, GH is envisioned to act briefly and reversibly via pituitary secretion to the arcuate-nucleus (36), which suppresses GHRH secretion at a threshold too low to induce SRIF release (14, 15) . However, both representations of autoregulation require a longer time delay for systemic GH concentrations to stimulate periventricular SRIF release and quench (otherwise indefinite) continuation of a multiphasic volley (6, 9, 20, 31, 34, 35, 37, 42) . SRIF release from nerve terminals in the median eminence terminates a volley by blocking somatotrope exocytosis (7, 9, 12, 16, 20, 24, 30, 32, 34, 37, 42) . GH feedback-induced outflow of SRIF into portal blood maintains low intervolley somatotrope secretion until GH concentrations decline by metabolic elimination in the circulation and CNS. Two Repression would be relieved by waning GH concentrations, thereby triggering rebound-like GHRH and GH secretion. The foregoing dynamics are concordant with selected biological oscillatory mechanisms that require implicit or explicit involvement of delayed negative feedback (17) .
Intervolley (nadir) GH concentrations in the adult male rat are undetectable in most current assays, consistent with prominent periventricular SRIF scretion induced by GH autofeedback (5, 6, 8, 9, 20, 29, 32) . In the female rodent, lesser GH-induced SRIF outflow would unmask activity of the proposed intrahypothalamic GHRH-SRIF oscillator mechanism otherwise made inapparent (albeit present) by pituitary inhibition due to cycles of autofeedback (14, 15, 20, 34, 35, 37) . Experimental data show that GHdependent feedback on SRIF neurons is attenuated, but not abolished, in the adult female rat (15, 19, 20, 31, 34, 37, 38, 42) . In the current formulation, partial, rather than complete, muting of GH autoinhibition in the female animal predicts occasional epochs of pluriphasic GH release, as observed under intensive (5-min) and extended (6-24 hr) monitoring of GH secretion in the female rodent and ruminant (19, 38, 42, 49) . A comparable inference of disinhibited GHRH-SRIF oscillatory activity would apply to the nearly continuous train of GH secretory bursts in the presumptively low SRIF milieu associated with fasting or deep sleep in the human (22, 26) .
Perspective
Silencing of CNS SRIF subtype 1-specific receptor function by Intracerebroventricular infusion of specific antisense oligodeoxynucleotide represses GH pulse amplitude in the adult male rat (28) . Such data demonstrate CNS autoregulation via SRIF-receptors, but do not establish the particular locus (loci) involved. In principle, topographically specific models of SRIF action could embody primarily arcuate (intra-) nuclear SRIF/GHRH connectivity or periventricular/arcuate (inter-) nuclear SRIF/GHRH linkages (12, 20, 24, 34, 35, 37, 42 and 8-fold (right). The feedforward (GHRH-on-SRIF) latency was increased by 4-fold and the hypothalamic uptake of the circulating peptide was assumed to be 100%. 
